These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2818086)

  • 1. [Antimicrobial activity of new beta-lactams and aminoglycosides in vitro under conditions of anaerobiosis].
    Bol'shakov LV; Bogomolova NS; Shenderov BA
    Antibiot Khimioter; 1989 Jul; 34(7):534-9. PubMed ID: 2818086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of aminoglycosides in face of introduction of new beta-lactam antibiotics in treatment of nosocomial infection.
    McGowan JE; McClellan DB; Irwin PS
    Infect Control; 1983; 4(6):440-3. PubMed ID: 6558023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative activity of 9 beta-lactamines, clindamycin and metronidazole on strictly anaerobic bacteria].
    Derriennic M; Reynaud A; Launay C; Courtieu AL
    Pathol Biol (Paris); 1987 May; 35(5):572-6. PubMed ID: 3302862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aerobic activity of metronidazole against anaerobic bacteria.
    Dione N; Khelaifia S; Lagier JC; Raoult D
    Int J Antimicrob Agents; 2015 May; 45(5):537-40. PubMed ID: 25813393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of dactimicin against aerobic and anaerobic bacteria isolated from intra-abdominal infections.
    Nord CE; Kager L
    Drugs Exp Clin Res; 1989; 15(3):113-4. PubMed ID: 2752908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
    Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
    Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the combination of clindamycin with beta-lactam antibiotics and aminoglycosides (author's transl)].
    Adam D; Nawrath I
    Arzneimittelforschung; 1981; 31(8):1295-8. PubMed ID: 7197536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    J Antimicrob Chemother; 2002 Sep; 50(3):411-20. PubMed ID: 12205068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of imipenem and 15 other antimicrobial agents against clinically important aerobic and anaerobic bacteria.
    Goldstein EJ; Citron DM
    Clin Ther; 1988; 10(5):487-515. PubMed ID: 2856592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of effectiveness of antibiotics by anaerobiosis.
    Verklin RM; Mandell GL
    J Lab Clin Med; 1977 Jan; 89(1):65-71. PubMed ID: 318675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HRE 664, a new parenteral penem. I. Antibacterial activity in vitro.
    Seibert G; Isert D; Klesel N; Limbert M; Pries A; Schrinner E; Cooke M; Walmsley J; Bentley PH
    J Antibiot (Tokyo); 1987 May; 40(5):660-7. PubMed ID: 3497140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility and beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections.
    Blandino G; Milazzo I; Fazio D; Puglisi S; Pisano M; Speciale A; Pappalardo S
    J Chemother; 2007 Oct; 19(5):495-9. PubMed ID: 18073147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of BU-2313B against anaerobic bacteria.
    Bansal MB; Dhawan VK; Thadepalli H
    Chemotherapy; 1982; 28(3):200-3. PubMed ID: 6920296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The sensitivity of anaerobic bacteria to chemotherapeutic agents (Zurich, 1991)].
    Wüst J; Hardegger U
    Schweiz Rundsch Med Prax; 1991 Dec; 80(52):1474-80. PubMed ID: 1815309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaerobic bacteria and beta-lactam antibiotics.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 42():72-82. PubMed ID: 6335601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of faropenem activity against anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Bryskier A
    J Chemother; 2005 Feb; 17(1):36-45. PubMed ID: 15828442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.